Skip to content

Author

Siddhant Krishna

We have 3 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Role of Targeted Biologic Therapies in the Management of Severe Asthma: A Review

Overall, biologic therapies have transformed the management of severe asthma by enabling more individualized treatment strategies, improving disease control, reducing exacerbation risk, and enhancing long-term clinical outcomes.

Siddhant Krishna, Qumar Negar, P. Goswami et al. · 0 citations
Review Sep 2026

Influence of Major Histocompatibility Complex (MHC) Diversity on Immune Modulation, Pathogenesis, and Control of Lumpy Skin Disease Virus.

Current evidence indicates that effective LSDV control requires integration of molecular diagnostics, vector management, vaccination, and host immunogenetics, and BoLAguided immunoinformatics provides promising opportunities for developing multi-epitope vaccines, although experimental validation remains essential.

Siddhant Krishna, Qumar Negar, P. Goswami et al. · 0 citations
#gene editing Review Sep 2026

Microbiome–Tumor–Host Interactions in Cancer Therapy: From Chemoresistance Mechanisms to Engineered Living Medicines

This review synthesizes recent advances in pharmaco‐microbiomics, reframing cancer treatment in a hologenetic context, with host, tumor and microbiome acting as a tripartite entity, and establishes microbiome as a predictor and therapeutic target in precision medicine.

Hailah M. Almohaimeed, Aniruddha Chatterjee, Sayani Ghosh et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.